Peritoneal Dialysis Clinical Trials
- Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?
ClinicalTrials.gov Identifier: NCT00125775 - Recruiting
Peritoneal Dialysis
- Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00119990 - Recruiting
Peritoneal Dialysis
- Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00421785 - Recruiting
ESRD; Peritoneal Dialysis
- Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00516061 - Recruiting
Peritoneal Dialysis
- Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD
ClinicalTrials.gov Identifier: NCT00447317 - Recruiting
End-Stage Renal Disease; Peritoneal Dialysis
- Longitudinal Evaluation of Volume Status in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00182338 - Recruiting
Cardiovascular Diseases; Inflammation; Peritoneal Dialysis
- The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00173602 - Recruiting
Peripheral Vascular Diseases; Peritoneal Dialysis
- Clinical Study of R744 to Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00433849 - Active, not recruiting
Peritoneal Dialysis Patients
- Targeting Peroxisome Proliferator-Activated Receptor-Gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
ClinicalTrials.gov Identifier: NCT00516880 - Recruiting
Chronic Disease; Kidney Diseases; Cardiovascular Diseases
- Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
ClinicalTrials.gov Identifier: NCT00299572 - Not yet recruiting
Peritoneal Dialysis
- Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
ClinicalTrials.gov Identifier: NCT00261625 - Not yet recruiting
End-Stage Renal Disease; Peritoneal Dialysis; Osteoporosis
- Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
ClinicalTrials.gov Identifier: NCT00369096 - Recruiting
Peritoneal Diseases
- Effects of Cognitive-Behavioral Therapy on Sleep Disturbance in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00155441 - Recruiting
sleep disorder:C23.888.592.796; peritoneal dialysis: F03.870.664
- Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00196755 - Completed
Peritoneal Dialysis; Chronic Kidney Disease
- Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology
ClinicalTrials.gov Identifier: NCT00407134 - Completed
Peritoneal Dialysis
- The Efficacy of Melatonin in Sleep Problems of Hemodialysis and Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00404456 - Recruiting
Hemodialysis; Peritoneal Dialysis; Sleep Problems
- Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00291863 - Recruiting
Renal Failure, End Stage; Peritoneal Dialysis
- Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00571194 - Recruiting
Pediatrics Patients on Dialysis
- MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00135863 - Terminated
Peritoneal Dialysis; Inflammation; Nutrition
- The Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00172471 - Completed
Renal Failure; Sleep Disorder; Hemodialysis; Peritoneal Dialysis
- Thalidomide for the Treatment of Malnutrition Inflammation Syndrome in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00390247 - Suspended
Peritoneal Dialysis; Malnutrition
- Use of Ointments in Prevention of Catheter Related Infections in PD
ClinicalTrials.gov Identifier: NCT00400595 - Recruiting
Peritoneal Dialysis
- The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00433264 - Recruiting
Chronic Kidney Disease
- The Effect of Antimicrobial Therapy on the Serum Level of p-Cresol in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00433342 - Recruiting
Chronic Kidney Disease
- A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
ClinicalTrials.gov Identifier: NCT00442416 - Recruiting
Anemia
- Method of Exit Site Care in Chronic Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00416338 - Terminated
Chronic Peritoneal Dialysis
- Acute Haemodynamic Impact of an IV Glucose-Injection
ClinicalTrials.gov Identifier: NCT00426114 - Not yet recruiting
Peritoneal Dialysis
- A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis
ClinicalTrials.gov Identifier: NCT00497744 - Recruiting
Peritonitis
- Safety Study to Evaluate Daptomycin in Non-Infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00490737 - Not yet recruiting
End-Stage Renal Disease
- Rates of Hospitalization in Home Care Assisted Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00499213 - Not yet recruiting
Rate of Hospitalization
- Continuous Hyperthermic Peritoneal Perfusion With Cisplatin Plus Intraperitoneal Paclitaxel and Fluorouracil Following Surgery in Treating Patients With Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00020059 - Recruiting
Carcinoma of the Appendix; Colorectal Cancer; Metastatic Cancer; Peritoneal Cavity Cancer
- A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00096993 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00332696 - Active, not recruiting
Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00491855 - Recruiting
Peritoneal Cancer
- The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate
ClinicalTrials.gov Identifier: NCT00173056 - Recruiting
Retroperitoneal Fibrosis
- Quality of Life Questionnaire for Pediatric Patients Undergoing Peritoneal Perfusion
ClinicalTrials.gov Identifier: NCT00502177 - Recruiting
Peritoneal Neoplasms
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00045682 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer
- Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00216372 - Recruiting
Intestinal Obstruction; Carcinoma; Peritoneal Neoplasms
- Evaluation of a New Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Lost Antibody After Previous Hepatitis B Vaccination.
ClinicalTrials.gov Identifier: NCT00291980 - Active, not recruiting
Hepatitis B
- FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
ClinicalTrials.gov Identifier: NCT00288613 - Recruiting
Kidney Failure, Chronic; End Stage Renal Disease, Requiring Dialysis
- A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00461786 - Active, not recruiting
Ovarian Cancer; Peritoneal Cancer
- Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005046 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00023712 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
ClinicalTrials.gov Identifier: NCT00291954 - Active, not recruiting
Hepatitis B Infection
- Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00093626 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00004081 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Sorafenib and Gemcitabine in Treating Patients With Recurrent or Refractory Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00096395 - Active, not recruiting
peritoneal cavity cancer; recurrent ovarian epithelial cancer
- Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
ClinicalTrials.gov Identifier: NCT00508885 - Completed
Hyperphosphatemia
- Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Randomized Phase III Study of 5-FU Versus MTX+5-FU in Gastric Cancer with Peritoneal Metastasis (JCOG0106-MF, MF/5FU)
ClinicalTrials.gov Identifier: NCT00149201 - Active, not recruiting
Gastric Cancer with Peritoneal Metastasis
- Suberoylanilide Hydroxamic Acid in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00132067 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00054119 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
ClinicalTrials.gov Identifier: NCT00506441 - Recruiting
Chronic Kidney Disease; Dialysis; Hyperphosphatemia
- Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00113373 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- BMS-247550 in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
ClinicalTrials.gov Identifier: NCT00025155 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00020696 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00086892 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00041041 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00087087 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Phase II Study in Patients with EGFR + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00063401 - Active, not recruiting
Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms
- Treatment of Peritoneal Cancer with Surgery, Perfused Heated Cisplatin and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004547 - Recruiting
Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm
- Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
ClinicalTrials.gov Identifier: NCT00006028 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00214695 - Completed
End Stage Renal Disease
- A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00214721 - Completed
End Stage Renal Disease
- Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis
ClinicalTrials.gov Identifier: NCT00236938 - Completed
Anemia
- Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin
ClinicalTrials.gov Identifier: NCT00239616 - Completed
Anemia
- Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00217568 - Active, not recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
ClinicalTrials.gov Identifier: NCT00537979 - Recruiting
Dialysis; Secondary Hyperparathyroidism
- Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00002895 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00006041 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
ClinicalTrials.gov Identifier: NCT00191646 - Active, not recruiting
Genital Neoplasms, Female; Fallopian Tube Neoplasms; Ovarian Neoplasms; Pelvic Neoplasms; Peritoneal Neoplasms
- Hormone Therapy With LY353381 Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003670 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Topotecan and Gefitinib (Iressa) for Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00317772 - Active, not recruiting
Ovarian Cancer; Peritoneal Neoplasms; Fallopian Tube Cancer
- Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
ClinicalTrials.gov Identifier: NCT00183794 - Recruiting
Ovarian Carcinoma; Peritoneal Neoplasms
- Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00008138 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003896 - Active, not recruiting
stage III ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Treatment for Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00052962 - Recruiting
Gastrointestinal Neoplasm
- Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003378 - Active, not recruiting
peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
- Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003560 - Active, not recruiting
Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00407563 - Recruiting
Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma
- Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00006391 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00059787 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00550784 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
- Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00026091 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00060359 - Active, not recruiting
Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
- A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00516841 - Recruiting
Ovarian Cancer; Peritoneal Neoplasms
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00011986 - Active, not recruiting
stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
- EPO906 Therapy in Patients with Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00035100 - Recruiting
Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms
- Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Treating Patients With Recurrent Late-Stage Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00091377 - Active, not recruiting
recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
- Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00217555 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Topotecan in Treating Patients With Progressive or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov Identifier: NCT00287859 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00217529 - Active, not recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00227721 - Recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Vaccine Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00408590 - Recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
ClinicalTrials.gov Identifier: NCT00436644 - Recruiting
Ovarian Cancer; Peritoneal Cavity Cancer
- Vascular Reactivity in Diabetic Dialysis Patients.
ClinicalTrials.gov Identifier: NCT00226902 - Recruiting
Kidney Failure, Chronic; Dialysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
